Huntsman Corporation reported a third quarter 2026 net loss of $18 million, an improvement from a $25 million loss in the prior year, alongside an adjusted net income of $7 million compared to a $5 million loss previously. Revenues rose 18% to $1.717 billion, driven by higher selling prices and volumes across its segments. The company is advancing its merger with Olin Corporation, having secured shareholder approval and regulatory clearances, expecting to complete the merger in early 2027. This merger aims to enhance shareholder value and operational efficiencies.
Huntsman Corporation's third quarter 2026 earnings report shows a net loss improvement to $18 million from $25 million a year earlier. For readers following the Basic Materials sector, here is Pluang's market snapshot as of Nov 03, 2026 04:11 WIB: out of 83 priced US stocks, 53 rose and 29 fell. Notable movers include Sherwin-Williams Company with a 5.95% gain and 100% sell order activity, Agnico Eagle Mines Ltd down 5.96% with 78% buy orders, and Gold Fields Limited down 5.89% with 88% sell orders.
The Geely E2 (EX2) electric car has reached one million units sold globally within two years of its launch in October 2024, marking rapid market acceptance. It became the world's best-selling car in A&B segments in 2025 and topped sales charts in cou...
AI data centers are expanding beyond traditional land-based locations due to increasing power and space constraints. Companies like Aikido Technologies are exploring floating data centers powered by offshore wind, while Elon Musk's SpaceX plans to de...
Global Indemnity Group will postpone its third quarter 2026 earnings call originally scheduled for November 4 to January, when new CEO Jessica Buss will present her vision and priorities for the company. The company will still release its Q3 results ...
Lorraine Ben, former CEO of Lockheed Martin Canada, has joined Syntax Defence to provide expert counsel amid Canada's commitment to invest over half a trillion dollars in defence over the next decade. This includes $180 billion in procurement opportu...
Zentalis Pharmaceuticals awarded 136,000 non-qualified stock options to four newly hired employees as an inducement to join the company, under Nasdaq Listing Rule 5635(c)(4). The options have an exercise price of $1.85, matching the stock's closing p...
